How is the Royalty Pharma plc - Ordinary Shares - Class A today?

The Royalty Pharma plc - Ordinary Shares - Class A today is trading in the down by -1.59% at 32.82.

How has Royalty Pharma plc - Ordinary Shares - Class A performed historically?

The Royalty Pharma plc - Ordinary Shares - Class A is currently trading down -1.59% on an intraday basis in the past week the index fell -0.55%. The index has been up 1.48% in the past quarter and rose 16.84% in the past year. You can view this in the overview section.

What is Royalty Pharma plc - Ordinary Shares - Class A Annual Revenue?

Royalty Pharma plc - Ordinary Shares - Class A Annual Revenue fell 3.86%, in the last year to $2,263.58 M. Its sector's average revenue growth for the last fiscal year was 8.63%.

What is Royalty Pharma plc - Ordinary Shares - Class A Annual Net Profit?

Royalty Pharma plc - Ordinary Shares - Class A Annual Net Profit fell 24.31% in the last year to $858.98 M. Its sector's average net profit growth for the last fiscal year was -7.19%.

What is Royalty Pharma plc - Ordinary Shares - Class A Price to Earning Ratio?

Royalty Pharma plc - Ordinary Shares - Class A Price to Earning Ratio is 12.66, higher than its sector PE ratio of 2.98.

What is Royalty Pharma plc - Ordinary Shares - Class A Stock Price?

Royalty Pharma plc - Ordinary Shares - Class A Stock Price rose 16.84% and outperformed its sector by 11.28% in the past year.

What is Royalty Pharma plc - Ordinary Shares - Class A Quarterly Revenue?

Royalty Pharma plc - Ordinary Shares - Class A Quarterly Revenue rose 0.05% YoY to $568.25 M. Its sector's average revenue growth YoY for the quarter was 2.8%.

What is Royalty Pharma plc - Ordinary Shares - Class A Quarterly Net profit?

Royalty Pharma plc - Ordinary Shares - Class A Quarterly Net profit rose 4,888.47% YoY to $238.35 M. Its sector's average net profit growth YoY for the quarter was -210.52%.

What is Royalty Pharma plc - Ordinary Shares - Class A Debt to Equity Ratio?

Royalty Pharma plc - Ordinary Shares - Class A Debt to Equity Ratio of 1.1 is higher than 1. This implies that company assets are financed through debt.

What is Royalty Pharma plc - Ordinary Shares - Class A Return on Equity(ROE)?

Royalty Pharma plc - Ordinary Shares - Class A Return on Equity(ROE) for the last financial year was 12.75%, in the normal range of 10% to 20%.

What is Royalty Pharma plc - Ordinary Shares - Class A Mutual Fund Holding?

Royalty Pharma plc - Ordinary Shares - Class A Mutual Fund Holding increased by 2.97% in the last quarter to 53.79.

What is Royalty Pharma plc - Ordinary Shares - Class A Interest Coverage Ratio?

Royalty Pharma plc - Ordinary Shares - Class A Interest Coverage Ratio is 6.9, higher than 1.5. This means that it is able to meet its interest payments comfortably with its earnings (EBIT).

What is Royalty Pharma plc - Ordinary Shares - Class A Institutional Holding?

Royalty Pharma plc - Ordinary Shares - Class A Institutional Holding increased by 0.89% in the last quarter to 75.78.

Royalty Pharma plc - Ordinary Shares - Class A XNAS: RPRX

Royalty Pharma plc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Royalty Pharma plc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Royalty Pharma plc - Ordinary Shares - Class A
Rating: 3.03452775
Author: Trendlyne DVM scores

Strong Performer

about

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

32.82 -0.53 (-1.59%)

Near 52W High of $34.20

4.4M XNAS Volume

XNAS 13 May, 2025 5:30 PM (EDT)

Dividend

Royalty Pharma plc - Ordinary Shares - Class A has an upcoming dividend of $0.22 per share due on 16 May 2025 See details

High Financial Strength

61.1 / 100

Affordable Valuation

54.0 / 100

Technically Moderately Bullish

66.5 / 100

Strong Performer These stock companies have strong financials and are affordably priced. They also score high in quality and technical aspects which makes them a favourite amongst investors. View Similar Embed DVM

1Yr Price target upside is 21%

7 analysts

Royalty Pharma plc - Ordin... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Royalty Pharma plc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

Near 52W High of $34.20

SWOT Analysis

Royalty Pharma plc - Ordin... Live Price Chart

Royalty Pharma plc - Ordinary Shares - Class A FAQ

How is Royalty Pharma plc - Ordinary Shares - Class A today?

Royalty Pharma plc - Ordinary Shares - Class A today is trading in the red, and is down by -1.59% at 32.82.

How has Royalty Pharma plc - Ordinary Shares - Class A performed historically?

Royalty Pharma plc - Ordinary Shares - Class A is currently trading down -1.59% on an intraday basis. In the past week the stock fell -0.55%. stock has been up 1.48% in the past quarter and rose 16.84% in the past year. You can view this in the overview section.